Ovarian hyperstimulation syndrome is a condition that may result from ovulation induction characterized by enlargement of the ovaries, fluid retention, and weight gain.
Help Get The Word Out - Link to ReproductiveFacts.org
View All
Ovarian hyperstimulation syndrome
Farmacos para la fertilidad y riesgo de partos multiples
Ovarian Hyperstimulation Syndrome (OHSS)
Síndrome de hiperestimulación ovárica-SHO (Ovarian hyperstimulation syndrome-OHSS)
Recommendations for practices utilitzing gestational carriers
The clinical relevance of luteal phase deficiency
Medicamentos Para Inducir La Ovulación (Medications for inducing ovulation)
Embarazo y Nacimientos Múltiples: Mellizos, Trillizos, o Mayor Número de Bebés (Multiple pregnancy and birth)
Gonadotropin Stimulation
GnRH Antagonist Therapy
Ovarian Hyperstimulation Syndrome
ART Medications
A Patient's Guide to Assisted Reproductive Technology
Continuing Medical Education
Polycystic ovary syndrome (PCOS)
Side effects of injectable fertility drugs (gonadotropins)
Risks of In Vitro Fertilization (IVF)
Members are allowed to have direct input in shaping policies and protocols in their area of expertise through ASRM affiliated societies, professional groups, and special interest groups.
Affiliates: SART | SMRU | SREI | SRBT | SRS
Professional Groups: ARM | LPG | MHPG | NPG
Special Interest Groups: AESIG | ChSIG | CSIG | EndoSIG | EPSIG | ERSIG | FPSIG | FSIG | HDSIG | GCSIG | IRMSIG | MSIG | NutriSIG | PAGSIG | PGDSIG | RISIG | RMSCBSIG | SSIG | WC